Cargando…
Harnessing tumor-associated macrophages as aids for cancer immunotherapy
Cancer immunotherapies that engage immune cells to fight against tumors are proving to be powerful weapons in combating cancer and are becoming increasingly utilized in the clinics. However, for the majority of patients with solid tumors, little or no progress has been seen, presumably due to lack o...
Autores principales: | Li, Xiaolei, Liu, Rui, Su, Xiao, Pan, Yongsha, Han, Xiaofeng, Shao, Changshun, Shi, Yufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894344/ https://www.ncbi.nlm.nih.gov/pubmed/31805946 http://dx.doi.org/10.1186/s12943-019-1102-3 |
Ejemplares similares
-
HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression
por: Li, Xiaolei, et al.
Publicado: (2021) -
Harnessing metabolism of hepatic macrophages to aid liver regeneration
por: Liu, Rui, et al.
Publicado: (2023) -
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
por: Li, Xiaolei, et al.
Publicado: (2018) -
Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
por: Zheng, Yanhui, et al.
Publicado: (2022) -
Harnessing the antitumor potential of macrophages for cancer immunotherapy
por: Long, Kristen B, et al.
Publicado: (2013)